← Home ← Back to /biz/

Thread 60541675

10 posts 4 images 10 unique posters /biz/
Anonymous (ID: nmM6pJdJ) No.60541675 >>60541720 >>60541974 >>60547150 >>60547454
Shill me some legit microcaps on hyperevm
Anonymous (ID: 37QpXQic) No.60541686
wrong hyper

the right one is hyperscale

the right man is dan hughes
Anonymous (ID: 9MAXvwyf) No.60541720
>>60541675 (OP)
hyper gonna take cardano soon
Anonymous (ID: 0Cq/Md/2) No.60541974 >>60545955
>>60541675 (OP)
GNS > HYPE
and its basically a mircocap
look into it
once HYPE runs out of hype merit takes over
GNS is now being sucked up to by arbitrum after arbitrum preferred GMX for years
becauuse GNS is superior.
GNS team unrivaled
I will be called retarded for posting this
Anonymous (ID: 4kPG8wux) No.60541995 >>60545879
why did shitcoins built on hyperliquid all die?

seems like its just only ever used for leverage trading big coins
Anonymous (ID: 99r8hzf0) No.60543949
Alephium
Anonymous (ID: 6tuuq3bV) No.60545879
>>60541995
That's the use case and it's actually being used for that which is rare amongst alts. Normally they say they do X but nobody uses it, they just buy the token and hold.
Anonymous (ID: 3885IGvY) No.60545955
>>60541974
Isn't hype cross chain but gns is not?
Anonymous (ID: VbWSuIOH) No.60547150
>>60541675 (OP)
>SUPRA
You're welcome
It exists on its own chain btw
Anonymous (ID: baXg8ODM) No.60547454
>>60541675 (OP)
Bro scamcoin HYPE just linked up with legit NASDAQ listed scamstock EYEN. The game done just got real, son.
>https://www.stocktitan.net/news/EYEN/eyenovia-announces-closing-of-50-million-private-placement-tjhuki3by2jn.html
>Eyenovia (NASDAQ: EYEN) has announced several major developments: the completion of a $50 million private placement, acquisition of over 1 million HYPE tokens at ~$34 each, and progress on its Optejet device. The company becomes the first Nasdaq-listed firm to run a validator on Hyperliquid blockchain and plans to rename itself to Hyperion DeFi (HYPD). The company's cryptocurrency strategy aims to leverage digital currency adoption while maintaining focus on its Optejet User Filled Device (UFD) development. The Optejet UFD is on schedule for FDA registration in September 2025, with verification and validation activities starting next month. The company is currently in discussions with potential partners for licensing the platform, particularly for OTC lens rewetting and artificial tears applications.